CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

GlobeNewswire Clinical Studies
Original article

Adial Pharmaceuticals Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

Neutral
AI Analysis

Summary

Adial Pharmaceuticals announced a stock option grant of 155,446 shares to a new employee as an inducement under Nasdaq Listing Rule 5635(c)(4).

Importance:2/10
Sentiment:
0.00
equity compensationstock optionNasdaq listing ruleinducement grant
Related Companies

Read the original article

Published by GlobeNewswire Clinical Studies on September 30, 2026 9:46 PM

Read Original